Follow Us
© 2026 Arizent. All rights reserved.
IMGCAP(1)]
WASHINGTON, Feb. 6 (Reuters) – Objections to Express Scripts’ $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as U.S. antitrust regulators weigh whether they have enough evidence to stop the megamerger.
For reprint and licensing requests for this article, click here.
The plan to eventually phase out rebates portends a seismic shift in the flow of billions of dollars among drugmakers, insurers and employers.
The future of employee wellness means that employers must balance strategies that combine meaningful new health and financial benefits.
The pharmacy landscape is shifting rapidly—and employers are feeling the pressure.
You may offer a world-class benefits package—but if employees don't understand or engage with what's available,
The incentives to encourage non-generic brands will encourage pharmacies to keep them in stock and increase their profits, says UnitedHealth's CEO.
